Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication

Siti Aisyah Abdul Ahmad, and Uma D.Palanisamy, and Tejo, Bimo A. and Chew, Miaw Fang * and Tham, Hong Wai and Sharifah Syed Hassan, (2017) Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication. Virology Journal, 14 (1). p. 229. ISSN 1743-422X

[img]
Preview
Text
Chew Miaw Fang Geraniin extracted from the rind.pdf

Download (1MB) | Preview
Official URL: http://dx.doi.org/10.1186/s12985-017-0895-1

Abstract

Background: The rapid rise and spread in dengue cases, together with the unavailability of safe vaccines and effective antiviral drugs, warrant the need to discover and develop novel anti-dengue treatments. In this study the antiviral activity of geraniin, extracted from the rind of Nephelium lappaceum, against dengue virus type-2 (DENV-2) was investigated. Methods: Geraniin was prepared from Nephelium lappaceum rind by reverse phase C-18 column chromatography. Cytotoxicity of geraniin towards Vero cells was evaluated using MTT assay while IC50 value was determined by plaque reduction assay. The mode-of-action of geraniin was characterized using the virucidal, attachment, penetration and the time-of-addition assays’. Docking experiments with geraniin molecule and the DENV envelope (E) protein was also performed. Finally, recombinant E Domain III (rE-DIII) protein was produced to physiologically test the binding of geraniin to DENV-2 E-DIII protein, through ELISA competitive binding assay. Results: Cytotoxicity assay confirmed that geraniin was not toxic to Vero cells, even at the highest concentration tested. The compound exhibited DENV-2 plaque formation inhibition, with an IC50 of 1.75 μM. We further revealed that geraniin reduced viral infectivity and inhibited DENV-2 from attaching to the cells but had little effect on its penetration. Geraniin was observed to be most effective when added at the early stage of DENV-2 infection. Docking experiments showed that geraniin binds to DENV E protein, specifically at the DIII region, while the ELISA competitive binding assay confirmed geraniin’s interaction with rE-DIII with high affinity. Conclusions: Geraniin from the rind of Nephelium lappaceum has antiviral activity against DENV-2. It is postulated that the compound inhibits viral attachment by binding to the E-DIII protein and interferes with the initial cell-virus interaction. Our results demonstrate that geraniin has the potential to be developed into an effective antiviral treatment, particularly for early phase dengue viral infection.

Item Type: Article
Uncontrolled Keywords: antiviral; DENV-2 E protein; Geraniin; Nephelium lappaceum
Subjects: Q Science > QH Natural history > QH301 Biology
Q Science > QR Microbiology > QR355 Virology
Divisions: Sunway University > Research Centres > Research Centre for Biomedical Sciences
Depositing User: Dr Janaki Sinnasamy
Date Deposited: 30 Nov 2017 02:59
Last Modified: 30 Jan 2018 09:31
URI: http://eprints.sunway.edu.my/id/eprint/690

Actions (login required)

View Item View Item